1. Parkinson’s disease (PD)
a. Hemisphere and systemic Parkinsonism
b. L-DOPA induced dyskinesia
c. PD with mild cognitive impairment (MCI)
2. Alzheimer’s Disease (AD)
a. Age-related AD-like neuropathic changes
b. AD-like biomarker changes induced by amyloid-β oligomer (ABO)
3. Brain Ischemia by middle cerebral artery occlusion (MCAO)
4. Epilepsy